- Home
- CLOV vs ATRC Comparison
CLOV vs ATRC Comparison
Compare CLOV & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLOV
- ATRC
- Stock Information
- Founded
- CLOV 2014
- ATRC 2000
- Country
- CLOV United States
- ATRC United States
- Employees
- CLOV N/A
- ATRC N/A
- Industry
- CLOV Medical Specialities
- ATRC Medical/Dental Instruments
- Sector
- CLOV Health Care
- ATRC Health Care
- Exchange
- CLOV Nasdaq
- ATRC Nasdaq
- Market Cap
- CLOV 1.8B
- ATRC 1.5B
- IPO Year
- CLOV N/A
- ATRC 2005
- Fundamental
- Price
- CLOV $3.14
- ATRC $34.57
- Analyst Decision
- CLOV Strong Buy
- ATRC Strong Buy
- Analyst Count
- CLOV 3
- ATRC 10
- Target Price
- CLOV $4.83
- ATRC $49.60
- AVG Volume (30 Days)
- CLOV 6.6M
- ATRC 581.4K
- Earning Date
- CLOV 05-06-2025
- ATRC 04-29-2025
- Dividend Yield
- CLOV N/A
- ATRC N/A
- EPS Growth
- CLOV N/A
- ATRC N/A
- EPS
- CLOV N/A
- ATRC N/A
- Revenue
- CLOV $1,486,540,000.00
- ATRC $480,076,000.00
- Revenue This Year
- CLOV $38.62
- ATRC $14.63
- Revenue Next Year
- CLOV $22.21
- ATRC $12.62
- P/E Ratio
- CLOV N/A
- ATRC N/A
- Revenue Growth
- CLOV 15.62
- ATRC 15.79
- 52 Week Low
- CLOV $0.90
- ATRC $18.94
- 52 Week High
- CLOV $4.87
- ATRC $43.11
- Technical
- Relative Strength Index (RSI)
- CLOV 38.35
- ATRC 60.03
- Support Level
- CLOV $3.16
- ATRC $31.95
- Resistance Level
- CLOV $3.28
- ATRC $34.08
- Average True Range (ATR)
- CLOV 0.16
- ATRC 1.14
- MACD
- CLOV -0.04
- ATRC 0.31
- Stochastic Oscillator
- CLOV 9.09
- ATRC 94.66
About CLOV Clover Health Investments Corp.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.